YTEN - Yield10 Bioscience, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 511.17M
Enterprise Value 311.82M
Trailing P/E N/A
Forward P/E 1-1.98
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)18.01
Price/Book (mrq)1.87
Enterprise Value/Revenue 319.07
Enterprise Value/EBITDA 6-1.34

Trading Information

Stock Price History

Beta (3Y Monthly) 1.46
52-Week Change 3-34.48%
S&P500 52-Week Change 37.06%
52 Week High 31.7700
52 Week Low 30.6800
50-Day Moving Average 30.8814
200-Day Moving Average 31.0444

Share Statistics

Avg Vol (3 month) 3149.92k
Avg Vol (10 day) 329.3k
Shares Outstanding 5N/A
Float 9.31M
% Held by Insiders 129.65%
% Held by Institutions 17.26%
Shares Short (Jun 28, 2019) 4567.71k
Short Ratio (Jun 28, 2019) 45.64
Short % of Float (Jun 28, 2019) 46.87%
Short % of Shares Outstanding (Jun 28, 2019) 44.54%
Shares Short (prior month May 31, 2019) 4538.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3May 30, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,450.48%

Management Effectiveness

Return on Assets (ttm)-41.43%
Return on Equity (ttm)-102.50%

Income Statement

Revenue (ttm)620k
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)106.70%
Gross Profit (ttm)-4.2M
EBITDA -8.79M
Net Income Avi to Common (ttm)-9.14M
Diluted EPS (ttm)-0.9020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.07M
Total Cash Per Share (mrq)0.49
Total Debt (mrq)6.27M
Total Debt/Equity (mrq)101.16
Current Ratio (mrq)4.49
Book Value Per Share (mrq)0.50

Cash Flow Statement

Operating Cash Flow (ttm)-8.02M
Levered Free Cash Flow (ttm)-5.27M